Autism BrainNet establishes collaboration with the Douglas-Bell Canada Brain Bank Autism BrainNet has established a new collaboration with the Douglas-Bell Canada Brain Bank. This alliance will allow Canadian individuals and families the opportunity to consider making a postmortem brain donation to help advance autism research.
SFARI Gene: New data release New data were recently added to SFARI Gene. This data release included updated gene scores for candidate autism risk genes, as well as the addition of new genes and copy number variant loci associated with autism. New mouse and rat models were also added.
SFARI Investigators elected to the National Academy of Sciences in 2019 Two SFARI Investigators are among the 100 newly elected members of the National Academy of Sciences.
SFARI posters at INSAR 2019 SFARI staff and collaborators will be presenting a number of posters about SFARI projects and resources at the International Society for Autism Research (INSAR) 2019 Annual Meeting in Montreal, Canada (May 1-4).
SFARI presentations at INSAR 2019 SFARI Investigators and SFARI science staff will be giving a number of oral presentations at the International Society for Autism Research (INSAR) 2019 Annual Meeting in Montreal, Canada (May 1-4).
SFARI Investigators elected to the American Academy of Arts & Sciences in 2019 Four current and former SFARI Investigators are among the more than 200 newly elected members of the American Academy of Arts & Sciences, one of the nation’s oldest and most prestigious honorary societies.
SFARI announces Genomic Analysis for Autism Risk Variants in SPARK awardees SFARI announces that it has awarded six grants in response to the Genomic Analysis for Autism Risk Variants in SPARK request for applications. These grants will help to advance the understanding of the genetic basis of autism spectrum disorder.
New SPARK clinical sites announced SFARI is pleased to announce that it has selected seven new clinical sites as a result of the 2019 SPARK Clinical Site Network request for applications. These sites will join the existing SPARK clinical site network and contribute to SPARK recruitment and engagement goals.